Sepio Capital’s Lifecore Biomedical LFCR Stock Holding History

Sepio Capital’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13,925	Closed	-$165K	–	270
2018 Q4	$165K	Buy	+13,925	New	+$191K	0.01%	279

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Sepio Capital's LFCR Position: Q1 2019 in Review

Sepio Capital sold out of Lifecore Biomedical (LFCR) in Q1 2019, closing a stake of 13,925 shares — an estimated $165K sold.

Sepio Capital first reported a position in LFCR in Q4 2018 and held it in 1 quarter. The position peaked at $165K in Q4 2018. 91 funds tracked by Wall St. Rank hold LFCR as of Q1 2019.

Sepio Capital reported no remaining Lifecore Biomedical position as of Q1 2019 after selling out during the quarter.
Sepio Capital sold 13,925 Lifecore Biomedical shares in Q1 2019, an estimated $165K.
Sepio Capital first reported a position in Lifecore Biomedical in Q4 2018 and held it in 1 quarter.
Sepio Capital's Lifecore Biomedical position peaked at $165K in Q4 2018.
91 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2019.

Based on Sepio Capital's 13F filing for Q1 2019, filed 14 May 2019.